Quick Heal Technologies Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/nkjj97g67ji3vda6r8cxhqvp.pdf

Key Takeaways


Consumer Business: The Cash Cow Under Pressure

Sanjay Katkar: "A consumer business which started 25 years ago is the cash cow segment for us. We do see cyclical upside and downside in the business as evident from our financial performance."

Enterprise Business: The Growth Story

Kailash Katkar: "We wanted to retain our leadership position when it comes to the enterprise in a small business and we wanted to aim our leadership position in the midsize sector maybe after one year we would definitely start focusing on large enterprise also part of it."

Strategy Reset: Management Consultant Engagement


New Products & Geographic Expansion

Sanjay Katkar: "The accelerating growth in the enterprise segment is making our convictions even stronger. We are establishing product market fit for all these products."

Investment Cycle & Margins


Market Position & Competitive Frame

Kailash Katkar: "When it comes to the consumer, we are still the market leader. We are still having more than 35% market share. ... we are at leadership position not for last two or three years, it is for almost 14 years actually."

Guidance & Commitments

CommitmentSpecificsTimeline
Consumer segment revivalFocused interventions on online/digital channels to return degrowing (11%) consumer segment to growth pathNo date given
Enterprise mid-segment pushAttain similar market share in mid customer segment (>500 endpoints) as currently held in micro segmentShort term (no date)
New product revenueZero trust and data privacy products to begin generating revenueH1 FY24
Large enterprise focusBegin focusing on large enterprise segmentAfter approximately one year
R&D spend rangeR&D spend at 30–32% of total revenueFY23 and a couple of quarters of FY24
Marketing spend rangeMarketing spend at similar elevated levelFY23 and a couple of quarters of FY24
Consultant-driven actionsSpecific actions from management consultant engagement to be disclosedComing quarters

Key Metrics

MetricQ2 FY23
Consolidated revenue₹101 cr, degrew 3% YoY
H1 FY23 consolidated revenue₹162 cr, grew 2% YoY
Consumer segment revenue share~70% of H1 FY23 revenue
Consumer segment growthdegrowing at 11%
Enterprise trailing 12-month revenue₹100+ cr, first time crossing this mark
Enterprise segment growth30%+, versus 23% last year and 11% market growth
Overall gross margin95%–96%
Enterprise gross margin90%–95%
Total expenses₹29 cr, up from ₹22 cr last quarter
R&D spend30% of total spend for the quarter; FY23 and early FY24 expected at 30%–32% of total revenue
Sales and marketing spend25% of spend equivalent to revenue; expected in similar range as R&D going forward
Consumer market sharemore than 35% in India, market leader for almost 14 years
Government revenue share in enterprisebroadly 20% of enterprise revenue
Total addressable market₹15,000 cr globally, enterprise commands over 95% share